Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

‘Every second counts’: New Viz.ai platform brings the entire heart attack team together
The new platform provides users with real-time access to high-quality electrocardiograms and patient data. The goal is to ensure everyone is on the same page at all times, with no unnecessary delays.
SCAI highlights the benefits of ICE-guided structural heart interventions
ICE is gaining momentum as a helpful imaging option during structural heart interventions, according to a new SCAI position statement. TEE and TTE remain incredibly important, but there are times when ICE can provide the guidance necessary.
Ultrasound renal denervation: A high-value treatment option for patients with uncontrolled hypertension
Nearly 120 million adults in the United States have hypertension, and just 1 in 4 of them have it under control. Treatments remain limited outside of lifestyle changes and hypertensive medications that are not always effective.
From heart pumps to politics: Former medtech CEO launches campaign to be the governor of Massachusetts
Michael Minogue spent nearly two decades as the chairman, president and CEO of Abiomed, and now he is running to be the next governor of Massachusetts.
DAPT during valve-in-valve TAVR may reduce stroke risk—more data still required
New research suggests there may be a cardiovascular benefit to considering dual antiplatelet therapy for valve-in-valve TAVR patients.

‘Every second counts’: New Viz.ai platform brings the entire heart attack team together

The new platform provides users with real-time access to high-quality electrocardiograms and patient data. The goal is to ensure everyone is on the same page at all times, with no unnecessary delays.

SCAI highlights the benefits of ICE-guided structural heart interventions

ICE is gaining momentum as a helpful imaging option during structural heart interventions, according to a new SCAI position statement. TEE and TTE remain incredibly important, but there are times when ICE can provide the guidance necessary.

Ultrasound renal denervation: A high-value treatment option for patients with uncontrolled hypertension

Sponsored by Recor Medical

Nearly 120 million adults in the United States have hypertension, and just 1 in 4 of them have it under control. Treatments remain limited outside of lifestyle changes and hypertensive medications that are not always effective.

Michael Minogue (center) and other Abiomed representatives. Image courtesy of Minogue's campaign.

From heart pumps to politics: Former medtech CEO launches campaign to be the governor of Massachusetts

Michael Minogue spent nearly two decades as the chairman, president and CEO of Abiomed, and now he is running to be the next governor of Massachusetts.

DAPT during valve-in-valve TAVR may reduce stroke risk—more data still required

New research suggests there may be a cardiovascular benefit to considering dual antiplatelet therapy for valve-in-valve TAVR patients.

Impella CP Johnson & Johnson MedTech Abiomed

Impella heart pump provides value during high-risk PCI, meta-analysis confirms

Using an Impella heart pump during high-risk PCI was linked to a reduced short-term mortality rate and an acceptable safety profile.

Cardiologists, heart surgeons sound alarm over widespread use of TAVR in low-risk patients

Are too many low-risk patients with severe AS undergoing TAVR instead of SAVR? According to one group of clinicians, "a significant public health concern may be looming."

Tracking the long-term safety of performing SAVR, other heart surgeries after TAVR

More and more TAVR patients are going to require SAVR later in life. A research team out of Cleveland Clinic hoped to learn more about how this one-two combination may impact long-term outcomes.